DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Canarypox
Canarypox
Evaluation of T-Cell and B-Cell Epitopes and Design of Multivalent Vaccines Against Htlv-1 Diseases
Evolution of the PRD1-Adenovirus Lineage: a Viral Tree of Life Incongruent with the Cellular 3 Universal Tree of Life 4 5 Authors 6 Anthony C
A Brief Speculative History of Avipoxvirus in New Zealand
Genomic Characterisation of a Novel Avipoxvirus Isolated from an Endangered Yellow-Eyed Penguin (Megadyptes Antipodes)
Safety of Intravenous Administration of a Canarypox Virus Encoding The
Avian Pox in Shearwaters on Lord Howe Island
HIV VACCINE RESEARCH and DEVELOPMENT CD8 Group
A History of AIDS: Looking Back to See Ahead
Comparative Efficacy of Feline Leukemia Virus
Canarypox Virus-Induced Maturation of Dendritic Cells Is Mediated by Apoptotic Cell Death and Tumor Necrosis Factor Alpha Secretion
Differential Innate Immune Stimulation Elicited by Adenovirus and Poxvirus Vaccine Vectors
Recombinant Type 3 Vaccine Technology
Characterization of Canarypox-Like Viruses Infecting Endemic Birds in the Galaâ Pagos Islands
Measuring the Humoral Immune Response in Cats Exposed to Feline Leukaemia Virus
Author's Personal Copy
IMMUNE RESPONSE to VACCINATION a Brief Review
HIV Vaccine Clinical Trials: an Overview
HIV-1 Recombinant Poxvirus Vaccine Induces Cross-Protection Against HIV-2 Challenge in Rhesus Macaques
Top View
VIRUSES This Concept Is Flawed Because a Hen Can Pass Anti- Bodies and Some Viruses to Her Offspring While the Egg Is Developing
HIV Pathogenesis and Vaccine Development
Scientists Slam Rationale Behind Largest HIV Vaccine Trial
Molecular Biological Characterization of Avian Poxvirus Strains Isolated
Applications of Pox Virus Vectors to Vaccination: an Update (Vaccinia/Fowipox/Canarypox/NYVAC Vaccinia) ENZO PAOLETTI Delmar, NY 12054
Technical Report HCSU-XXX
Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti
Viruses As Vaccine Vectors for Infectious Diseases and Cancer
Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats
Canarypox Virus Expressing Wild Type P53 for Gene Therapy in Murine
Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination
Mining the Mechanisms of an HIV Vaccine
Vcp97 Recombinant Canarypoxvirus (Felv)107.5 CCID50 (Cell Culture Infectious Dose 50%)
Evaluation of the Efficacy Provided by a Recombinant Canarypox
An Update on the HIV DNA Vaccine Strategy
A Comparative Study of the Efficacy of a Canarypox Based Recombinant
Vaccines Responses Induced by Canarypox Virus Characterization of Antigen-Specific Immune
Vaccine Developments
Stuke, K. Et Al. Efficacy of an Inactivated Felv Vaccine Compared to a Recombinant Felv Vaccine in Minimum Age Cats Following Virulent Felv Challenge
Cat Vaccination Guidelines
PUREVAX® Recombinant Felv
Proteqflu : EPAR
An HIV Vaccine: How and When? Jose´ Esparza1